Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 4. Effects of AUY954 on mRNA expression levels of M2 markers in post-ischemic brain. Mice were challenged with tMCAO. AUY954 (AUY, 5 mg/kg, p.o.) was then administered immediately after reperfusion. Expression levels of CD206, CCL-22, Arg1, and TGF-β1 mRNAs were assessed in the brain through qRT-PCR analysis at 1 day (A–D) or 3 days (E–H) after tMCAO challenge. n=4–5 mice per group. *p<0.05 and **p<0.01 versus sham group. #p<0.05 versus vehicle-administered tMCAO mice (tMCAO+veh).
Biomolecules & Therapeutics 2019;27:522~529 https://doi.org/10.4062/biomolther.2019.005
© Biomolecules & Therapeutics